|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pellegriti G, Frasca F, Regalbuto C,
Squatrito S and Vigneri R: Worldwide increasing incidence of
thyroid cancer: Update on epidemiology and risk factors. J Cancer
Epidemiol. 2013:9652122013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schneider DF and Chen H: New developments
in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin.
63:374–394. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rosenbaum MA and McHenry CR: Contemporary
management of papillary carcinoma of the thyroid gland. Expert Rev
Anticancer Ther. 9:317–329. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brosnan CA and Voinnet O: The long and the
short of noncoding RNAs. Curr Opin Cell Biol. 21:416–425. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi
Y and Guo J: Long noncoding RNA associated-competing endogenous
RNAs in gastric cancer. Sci Rep. 4:60882014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Fan D, Jian Z, Chen GG and Lai P:
Cancer specific long noncoding RNAs show differential expression
patterns and competing endogenous RNA potential in hepatocellular
carcinoma. PLoS One. 10:e01410422015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang K, Li Q, Kang X, Wang Y and Wang S:
Identification and functional characterization of lncRNAs acting as
ceRNA involved in the malignant progression of glioblastoma
multiforme. Oncol Rep. 36:2911–2925. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sui J, Li YH, Zhang YQ, Li CY, Shen X, Yao
WZ, Peng H, Hong WW, Yin LH, Pu YP, et al: Integrated analysis of
long non-coding RNA-associated ceRNA network reveals potential
lncRNA biomarkers in human lung adenocarcinoma. Int J Oncol.
49:2023–2036. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu L, Yang J, Zhu X, Li D, Lv Z and Zhang
X: Long noncoding RNA H19 competitively binds miR-17-5p to regulate
YES1 expression in thyroid cancer. FEBS J. 283:2326–2339. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arancio W, Carina V, Pizzolanti G,
Tomasello L, Pitrone M, Baiamonte C, Amato MC and Giordano C:
Anaplastic thyroid carcinoma: A ceRNA analysis pointed to a
crosstalk between SOX2, TP53, and microRNA biogenesis. Int J
Endocrinol. 2015:4393702015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang CT, Oyang YJ, Huang HC and Juan HF:
MicroRNA-mediated networks underlie immune response regulation in
papillary thyroid carcinoma. Sci Rep. 4:64952015. View Article : Google Scholar
|
|
18
|
Lan X, Zhang H, Wang Z, Dong W, Sun W,
Shao L, Zhang T and Zhang D: Genome-wide analysis of long noncoding
RNA expression profile in papillary thyroid carcinoma. Gene.
569:109–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jeggari A, Marks DS and Larsson E:
miRcode: A map of putative microRNA target sites in the long
non-coding transcriptome. Bioinformatics. 28:2062–2063. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Riffo-Campos ÁL, Riquelme I and
Brebi-Mieville P: Tools for sequence-based miRNA target prediction:
What to choose? Int J Mol Sci. 17(pii): E19872016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hsu SD, Lin FM, Wu WY, Liang C, Huang WC,
Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM, et al: miRTarBase: A
database curates experimentally validated microRNA-target
interactions. Nucleic Acids Res. 39:D163–D169. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
LiVolsi VA: Papillary thyroid carcinoma:
An update. Mod Pathol. 24 Suppl 2:S1–S9. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tunca F, Sormaz IC, Iscan Y, Senyurek YG
and Terzioglu T: Comparison of histopathological features and
prognosis of classical and follicular variant papillary thyroid
carcinoma. J Endocrinol Invest. 38:1327–1334. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xing M: Molecular pathogenesis and
mechanisms of thyroid cancer. Nat Rev Cancer. 13:184–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Aragon Han P, Weng CH, Khawaja HT,
Nagarajan N, Schneider EB, Umbricht CB, Witwer KW and Zeiger MA:
MicroRNA expression and association with clinicopathologic features
in papillary thyroid cancer: A systematic review. Thyroid.
25:1322–1329. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Q, Li H, Zhang L, Zhang C, Yan W and
Wang C: Identification of novel long non-coding RNA biomarkers for
prognosis prediction of papillary thyroid cancer. Oncotarget.
8:46136–46144. 2017.PubMed/NCBI
|
|
29
|
Ergun S and Oztuzcu S: Oncocers:
ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways.
Tumor Biol. 36:3129–3136. 2015. View Article : Google Scholar
|
|
30
|
Yang M, Tian J, Guo X, Yang Y, Guan R, Qiu
M, Li Y, Sun X, Zhen Y, Zhang Y, et al: Long noncoding RNA are
aberrantly expressed in human papillary thyroid carcinoma. Oncol
Lett. 12:544–552. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xie J, Guo B, Ding Z, Kang J, Deng X, Wu B
and Fan Y: Microarray analysis of lncRNAs and mRNAs co-expression
network and lncRNA function as ceRNA in papillary thyroid
carcinoma. J Biomater Tiss Eng. 5:872–880. 2015. View Article : Google Scholar
|
|
32
|
Chen Z, Li J, Lin S, Cao C, Gimbrone NT,
Yang R, Fu DA, Carper MB, Haura EB, Schabath MB, et al:
cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer
and mediates tumor growth. J Clin Invest. 126:2267–2279. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Y, Tao Y and Liao Q: Long noncoding
RNA: A crosslink in biological regulatory network. Brief Bioinform.
Apr 24–2017.(Epub ahead of print).
|
|
34
|
Cao W, Liu JN, Liu Z, Wang X, Han ZG, Ji
T, Chen WT and Zou X: A three-lncRNA signature derived from the
Atlas of ncRNA in cancer (TANRIC) database predicts the survival of
patients with head and neck squamous cell carcinoma. Oral Oncol.
65:94–101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Onda M, Nagai H, Yoshida A, Miyamoto S,
Asaka S, Akaishi J, Takatsu K, Nagahama M, Ito K, Shimizu K and Emi
M: Up-regulation of transcriptional factor E2F1 in papillary and
anaplastic thyroid cancers. J Hum Genet. 49:312–318. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hallstrom TC, Mori S and Nevins JR: An
E2F1-dependent gene expression program that determines the balance
between proliferation and cell death. Cancer Cell. 13:11–22. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tian W, Cui F and Esteban MA: E2F1 in
renal cancer: Mr Hyde disguised as Dr Jekyll? J Pathol.
231:143–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhan L, Zhang Y, Wang W, Song E, Fan Y and
Wei B: E2F1: A promising regulator in ovarian carcinoma. Tumour
Biol. 37:2823–2831. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dar AA, Majid S, de Semir D, Nosrati M,
Bezrookove V and Kashani-Sabet M: miRNA-205 suppresses melanoma
cell proliferation and induces senescence via regulation of E2F1
protein. J Biol Chem. 286:16606–16614. 2011. View Article : Google Scholar : PubMed/NCBI
|
